Sunitinib Plus Paclitaxel Versus Bevacizumab Plus Paclitaxel for First-Line Treatment of Patients With Advanced Breast Cancer: A Phase III, Randomized, Open-Label Trial
Titel:
Sunitinib Plus Paclitaxel Versus Bevacizumab Plus Paclitaxel for First-Line Treatment of Patients With Advanced Breast Cancer: A Phase III, Randomized, Open-Label Trial
Auteur:
Robert, Nicholas J. Saleh, Mansoor N. Paul, Devchand Generali, Daniele Gressot, Laurent Copur, Mehmet S. Brufsky, Adam M. Minton, Susan E. Giguere, Jeffrey K. Smith II, John W. Richards, Paul D. Gernhardt, Diana Huang, Xin Liau, Katherine F. Kern, Kenneth A. Davis, John